Literature DB >> 25323008

Inhibitory effects of oligochitosan on TNF-α, IL-1β and nitric oxide production in lipopolysaccharide-induced RAW264.7 cells.

Jie Zhu1, Yuanyuan Zhang2, Guoyou Wu1, Zhen Xiao1, Huanqin Zhou1, Xiaomei Yu1.   

Abstract

Oligochitosan has been reported to possess anti-inflammatory properties; however, the mechanism of the antiinflammatory effects of oligochitosan remains unknown. The present study aimed to investigate the expression levels of inflammatory cytokines and the production of nitric oxide (NO), in the nuclear factor (NF)-κB pathway of lipopolysaccharide (LPS)-stimulated RAW264.7 murine macrophages. The results of the present study demonstrated that different concentrations of oligochitosan could significantly lower the levels of NO, tumor necrosis factor (TNF)-α and interleukin (IL)-1β, released from LPS-stimulated RAW264.7 cells. This was shown to be mediated through inhibiting the activation of the NF-κB pathway. These results demonstrate that oligochitosan may efficiently inhibit inflammation and has the potential to be an effective anti-inflammatory agent.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25323008     DOI: 10.3892/mmr.2014.2643

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  4 in total

Review 1.  The potential of chitosan and its derivatives in prevention and treatment of age-related diseases.

Authors:  Garry Kerch
Journal:  Mar Drugs       Date:  2015-04-13       Impact factor: 5.118

Review 2.  A Review of the Preparation, Analysis and Biological Functions of Chitooligosaccharide.

Authors:  Shuang Liang; Yaxuan Sun; Xueling Dai
Journal:  Int J Mol Sci       Date:  2018-07-27       Impact factor: 5.923

3.  MicroRNA-181a-5p Regulates Inflammatory Response of Macrophages in Sepsis.

Authors:  Zheng Huang; Hang Xu
Journal:  Open Med (Wars)       Date:  2019-11-20

Review 4.  Effectiveness of Chitosan as a Dietary Supplement in Lowering Cholesterol in Murine Models: A Meta-Analysis.

Authors:  Sung-Il Ahn; Sangbuem Cho; Nag-Jin Choi
Journal:  Mar Drugs       Date:  2021-01-09       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.